In vitro evaluation of nanoliposomal doxorubicin modified with tat peptide developed by post-insertion method on C-26 colon carcinoma cell line

M.R. Bagheri, M. Amin, A. Badiee, M. Jaafari

Abstract


  

Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.